Cautious Optimism For US FDA Commissioner Nominee’s Self-Professed Data Driven Approach

Donald Trump's FDA commissioner nominee may be well positioned to continue Robert Califf's campaign against misinformation, but some concerns linger. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Geography